Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Rating Lowered by Wall Street Zen
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued on Saturday. A number of other analysts have also recently commented on the company. Canaccord Genuity Group upped their price target on Alnylam Pharmaceuticals from $385.00 to […]
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued on Saturday. A number of other analysts have also recently commented on the company. Canaccord Genuity Group upped their price target on Alnylam Pharmaceuticals from $385.00 to […]
